The emerging role of extracellular HSP90 in prostate cancer progression to a metastatic phenotype

被引：0
|
作者：
O'Neill, Katelyn
Zigmond, Johnny
Bergan, Raymond
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-3353
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3353
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Targeting Hsp90 for the treatment of cancer
    Drysdale, Martin J.
    Brough, Paul A.
    Massey, Andrew
    Jensen, Michael Rugaard
    Schoepfer, Joseph
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2006, 9 (04) : 483 - 495
  • [42] Targeting HSP90 for cancer therapy
    D Mahalingam
    R Swords
    J S Carew
    S T Nawrocki
    K Bhalla
    F J Giles
    British Journal of Cancer, 2009, 100 : 1523 - 1529
  • [43] HSP90 and Immune Modulation in Cancer
    Graner, Michael W.
    HSP90 IN CANCER: BEYOND THE USUAL SUSPECTS, 2016, 129 : 191 - 224
  • [44] Cell Stress Induced Stressome Release Including Damaged Membrane Vesicles and Extracellular HSP90 by Prostate Cancer Cells
    Eguchi, Takanori
    Sogawa, Chiharu
    Ono, Kisho
    Matsumoto, Masaki
    Manh Tien Tran
    Okusha, Yuka
    Lang, Benjamin J.
    Okamoto, Kuniaki
    Calderwood, Stuart K.
    CELLS, 2020, 9 (03)
  • [45] Emerging Role of Extracellular Vesicles in Prostate Cancer
    Ludwig, Megan
    Rajvansh, Rhea
    Drake, Justin M.
    ENDOCRINOLOGY, 2021, 162 (09)
  • [46] A critical role for HSP90 in cancer cell invasion involves interaction with the extracellular domain of HER-2
    Sidera, Katerina
    Gaitanou, Maria
    Stellas, Dimitris
    Matsas, Rebecca
    Patsavoudi, Evangelia
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (04) : 2031 - 2041
  • [47] Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
    Kang, B. H.
    Tavecchio, M.
    Goel, H. L.
    Hsieh, C. -C
    Garlick, D. S.
    Raskett, C. M.
    Lian, J. B.
    Stein, G. S.
    Languino, L. R.
    Altieri, D. C.
    BRITISH JOURNAL OF CANCER, 2011, 104 (04) : 629 - 634
  • [48] Inhibition of Hsp90 Augments Docetaxel Therapy in Castrate Resistant Prostate Cancer
    Ku, ShengYu
    Lasorsa, Elena
    Adelaiye, Remi
    Ramakrishnan, Swathi
    Ellis, Leigh
    Pili, Roberto
    PLOS ONE, 2014, 9 (07):
  • [49] Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease
    B H Kang
    M Tavecchio
    H L Goel
    C-C Hsieh
    D S Garlick
    C M Raskett
    J B Lian
    G S Stein
    L R Languino
    D C Altieri
    British Journal of Cancer, 2011, 104 : 629 - 634
  • [50] EGCG inhibits Hsp90 function by impairing Hsp90 association with cochaperones in pancreatic cancer cells
    Li, Yanyan
    Zhang, Tao
    Schwartz, Steven
    Sun, Duxin
    CANCER RESEARCH, 2009, 69
12345